Diagnolita
+370 688 12972
info@diagnolita.lt
  • LT
0
  • Shop
    • COVID-19 PCR test
    • Non-invasive prostate cancer test
    • Genetic testing of hereditary breast and ovarian cancer
  • Scientific activities
    • Scientific Projects
    • Publications and Conference Presentations
    • Kits
  • FAQ
  • Contacts
  • About COVID-19 PCR saliva testing
  • About hereditary breast and ovarian cancer
  • About prostate cancer
  • About SARS-CoV-2 virus
  • Cart
  • Checkout
  • Contacts
  • COVID-19 diagnostics
  • Diagnosis of breast cancer
  • Diagnosis of ovarian cancer
  • FAQ
  • Homepage
  • Kits
  • Molecular biomarkers
  • My account
  • Privacy policy
  • Prostate biopsy
  • Prostate cancer diagnosis
  • Prostate Cancer Risk Calculator
  • Publications and Conference Presentations
  • Research scheme
  • Samples of Diagnolita‘s test results
  • Scientific activities
  • Scientific Projects
  • Shop
  • Test example: BRCA results
  • Test Result
  • Test Result: Invalid
  • Test Result: Negative
  • Test Result: Pending
  • Test Result: Positive

Category: Prostate cancer biomarker test

Where can the test be taken?

Does the National Health Insurance Fund reimburse the test?

What does it mean if the overall probability of prostate cancer exceeds the cutoff value and that of significant cancer does not?

When do you recommend repeating the test if the calculated risk values do not exceed the cut-off values?

Do I need to see a doctor after receiving the test result?

How to pack the collected sample properly for shipping?

Where should the urine sample be stored?

What urine is required for the test?

How to prepare a urine sample properly?

What medications can affect the test? And how?

Is it worth taking the test when the PSA concentration in the serum does not fall within the recommended range of 2-10 ng/ml?

Can the test be taken in Diagnolita’s facilities?

Where should I look for the test?

Is it possible to take the test without prostate massage? Is the result less accurate in this case?

Will the Diagnolita prostate cancer test replace the serum PSA test?

When is Diagnolita’s prostate cancer test recommended?

  • 1
  • 2
  • »

JSC „Diagnolita“

Company code: 303128944
VAT code: LT100008093814

Diagnostics center

Vilnius University Technology Business Incubator, Saulėtekio alėja.
Saulėtekio alėja 7C, Vilnius, LT-10257

info@diagnolita.lt

+370 688 12972

Working hours

I-IV: 8 – 17 val.


V: 8 – 16 val.

COVID-19 virus

  • COVID-19 PCR test
  • About SARS-CoV-2 virus
  • COVID-19 diagnostics
  • About COVID-19 PCR saliva testing
  • Research scheme

Hereditary breast and ovarian cancer

  • Genetic testing of hereditary breast and ovarian cancer
  • About hereditary breast and ovarian cancer
  • Diagnosis of breast cancer
  • Diagnosis of ovarian cancer
  • Test example: BRCA results
  • Molecular biomarkers

Prostate cancer

  • Prostate cancer biomarker test
  • About prostate cancer
  • Prostate biopsy
  • Prostate cancer diagnosis
  • Samples of Diagnolita‘s test results
  • Prostate Cancer Risk Calculator

For clients

  • My account
  • Frequently asked questions

Scientific activities

  • Scientific Projects
  • Publications
  • Kits

2025 © UAB „Diagnolita“.
All rights reserved. Privacy policy

https://www.linkedin.com/company/diagnolita/about/ https://www.facebook.com/diagnolita.lt

Solution: Verslum.lt

Cookies are used for statistical and marketing purposes. By pressing “I agree” button or continuing to browse, you confirm that. More about cookies and their withdrawn, please read our Privacy policy.